Literature DB >> 17676877

Contribution of A1 subunit residue Q316 in thrombin-activated factor VIII to A2 subunit dissociation.

Ernest T Parker1, Pete Lollar.   

Abstract

Blood coagulation factor VIII (fVIII) is activated by thrombin to form an A1/A2/A3-C1-C2 heterotrimer, which functions as a cofactor for factor IXa during intrinsic pathway factor X activation. Human thrombin-activated fVIII (fVIIIa) decays rapidly because of first-order dissociation of the A2 subunit, which may function to regulate the coagulation mechanism. The three fVIII A domains each consist of two cupredoxin-like subdomains. Substitution of the COOH-terminal A1 subdomain of porcine fVIIIa, which decays more slowly than human fVIIIa, reduces the dissociation rate constant for fVIIIa decay. Examination of a human fVIII A1-A2-A3 homology model [Pemberton, S., et al. (1997) Blood 89, 2413-2421) revealed a possible interaction between Q316 in the FG helix of the COOH-terminal A1 subdomain and M539 in the FG helix of the NH2-terminal A2 subdomain, which are sites where human and porcine fVIII differ. Decays of purified recombinant human and porcine fVIIIa and the human fVIIIa mutants Q316H, M539L and Q316H/M539L were compared at 23 and 37 degrees C. The decay rates of the Q316H and Q316H/M539L mutants, but not the M539L mutant, were significantly slower than human fVIIIa. These results indicate that the FG helix of the COOH-terminal A1 cupredoxin-like subdomain of fVIII may be under selective pressure by the requirements of hemostatic balance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17676877      PMCID: PMC2525606          DOI: 10.1021/bi700941w

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  36 in total

1.  The crystal structure of activated protein C-inactivated bovine factor Va: Implications for cofactor function.

Authors:  Ty E Adams; Matthew F Hockin; Kenneth G Mann; Stephen J Everse
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

2.  Activation of porcine factor VIII:C by thrombin and factor Xa.

Authors:  P Lollar; G J Knutson; D N Fass
Journal:  Biochemistry       Date:  1985-12-31       Impact factor: 3.162

3.  Coagulation factors V and VIII and ceruloplasmin constitute a family of structurally related proteins.

Authors:  W R Church; R L Jernigan; J Toole; R M Hewick; J Knopf; G J Knutson; M E Nesheim; K G Mann; D N Fass
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

4.  Structure of human factor VIII.

Authors:  G A Vehar; B Keyt; D Eaton; H Rodriguez; D P O'Brien; F Rotblat; H Oppermann; R Keck; W I Wood; R N Harkins; E G Tuddenham; R M Lawn; D J Capon
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

5.  Stabilization of thrombin-activated porcine factor VIII:C by factor IXa phospholipid.

Authors:  P Lollar; G J Knutson; D N Fass
Journal:  Blood       Date:  1984-06       Impact factor: 22.113

6.  Identification of porcine coagulation factor VIII domains responsible for high level expression via enhanced secretion.

Authors:  Christopher B Doering; John F Healey; Ernest T Parker; Rachel T Barrow; Pete Lollar
Journal:  J Biol Chem       Date:  2003-12-01       Impact factor: 5.157

7.  pH-dependent denaturation of thrombin-activated porcine factor VIII.

Authors:  P Lollar; C G Parker
Journal:  J Biol Chem       Date:  1990-01-25       Impact factor: 5.157

8.  Human factor VIIIa subunit structure. Reconstruction of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunit.

Authors:  P J Fay; P J Haidaris; T M Smudzin
Journal:  J Biol Chem       Date:  1991-05-15       Impact factor: 5.157

9.  Subunit structure of thrombin-activated porcine factor VIII.

Authors:  P Lollar; C G Parker
Journal:  Biochemistry       Date:  1989-01-24       Impact factor: 3.162

10.  The activation and inactivation of human factor VIII by thrombin: effect of inhibitors of thrombin.

Authors:  M B Hultin; J Jesty
Journal:  Blood       Date:  1981-03       Impact factor: 22.113

View more
  2 in total

1.  Stabilizing interactions between D666-S1787 and T657-Y1792 at the A2-A3 interface support factor VIIIa stability in the blood clotting pathway.

Authors:  M Monaghan; H Wakabayashi; A E Griffiths; P J Fay
Journal:  J Thromb Haemost       Date:  2016-03-21       Impact factor: 5.824

2.  The 3.2 Å structure of a bioengineered variant of blood coagulation factor VIII indicates two conformations of the C2 domain.

Authors:  Ian W Smith; Anne E d'Aquino; Christopher W Coyle; Andrew Fedanov; Ernest T Parker; Gabriela Denning; Harold Trent Spencer; Pete Lollar; Christopher B Doering; Paul Clint Spiegel
Journal:  J Thromb Haemost       Date:  2019-09-08       Impact factor: 5.824

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.